Literature DB >> 19663601

False homozygous deletions of SMN1 exon 7 using Dra I PCR-RFLP caused by a novel mutation in spinal muscular atrophy.

Seong-Ho Kang1, Sung Im Cho, Jong-Hee Chae, Kyu Nam Chung, Eun Kyung Ra, So Yeon Kim, Moon-Woo Seong, Ji Yeon Kim, Sung Sup Park.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder, and about 95% of SMA patients are homozygous for deletions in the SMN1 gene. Herein, classical polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) using DraI yielded false homozygous deletions of SMN1 exon 7 in a patient with SMA, but multiple ligation-dependent probe amplification analysis revealed one remaining copy of SMN1 exon 7. Sequencing showed that this false deletion in the PCR-RFLP resulted from a novel mutation of one SMN1 copy that was not deleted (c.863G > T, p.R288M). This novel sequence variant introduced a mismatch that interfered with primer binding. These findings demonstrate that comprehensive analysis using PCR-RFLP, multiple ligation-dependent probe amplification, and sequencing can reliably and correctly diagnose SMA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19663601     DOI: 10.1089/gtmb.2008.0158

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  3 in total

1.  Rare Variants in RPPH1 Real-Time Quantitative PCR Control Assay Binding Sites Result in Incorrect Copy Number Calls.

Authors:  Robert J Sicko; Paul A Romitti; Marilyn L Browne; Lawrence C Brody; Colleen F Stevens; James L Mills; Michele Caggana; Denise M Kay
Journal:  J Mol Diagn       Date:  2021-10-15       Impact factor: 5.568

2.  Subtle mutations in the SMN1 gene in Chinese patients with SMA: p.Arg288Met mutation causing SMN1 transcript exclusion of exon7.

Authors:  Qu Yu-Jin; Du Juan; Li Er-zhen; Bai Jin-li; Jin Yu-wei; Wang Hong; Song Fang
Journal:  BMC Med Genet       Date:  2012-09-20       Impact factor: 2.103

3.  Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?

Authors:  Igor Araujo Vieira; Tiago Finger Andreis; Bruna Vieira Fernandes; Maria Isabel Achatz; Gabriel S Macedo; Daniel Schramek; Patricia Ashton-Prolla
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.